These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35055131)

  • 1. Common and Distinctive Intercellular Communication Patterns in Human Obstructive and Nonobstructive Hypertrophic Cardiomyopathy.
    Codden CJ; Chin MT
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Nucleus RNA-sequencing Reveals Altered Intercellular Communication and Dendritic Cell Activation in Nonobstructive Hypertrophic Cardiomyopathy.
    Codden CJ; Larson A; Awata J; Perera G; Chin MT
    Cardiol Cardiovasc Med; 2022; 6(4):398-415. PubMed ID: 36237479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy.
    Larson A; Codden CJ; Huggins GS; Rastegar H; Chen FY; Maron BJ; Rowin EJ; Maron MS; Chin MT
    Sci Rep; 2022 Mar; 12(1):5211. PubMed ID: 35338173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve.
    Ro R; Halpern D; Sahn DJ; Homel P; Arabadjian M; Lopresto C; Sherrid MV
    J Am Coll Cardiol; 2014 Nov; 64(19):1984-95. PubMed ID: 25440093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.
    Maron MS; Rowin EJ; Olivotto I; Casey SA; Arretini A; Tomberli B; Garberich RF; Link MS; Chan RHM; Lesser JR; Maron BJ
    J Am Coll Cardiol; 2016 Mar; 67(12):1399-1409. PubMed ID: 27012399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
    Bravo PE; Pinheiro A; Higuchi T; Rischpler C; Merrill J; Santaularia-Tomas M; Abraham MR; Wahl RL; Abraham TP; Bengel FM
    J Nucl Med; 2012 Mar; 53(3):407-14. PubMed ID: 22315440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.
    Śpiewak M; Kłopotowski M; Gawor M; Kubik A; Kowalik E; Miłosz-Wieczorek B; Dąbrowski M; Werys K; Mazurkiewicz Ł; Kożuch K; Polańska-Skrzypczyk M; Petryka-Mazurkiewicz J; Klisiewicz A; Bilińska ZT; Grzybowski J; Witkowski A; Marczak M
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):105. PubMed ID: 29268761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype.
    Güçlü A; Happé C; Eren S; Korkmaz IH; Niessen HW; Klein P; van Slegtenhorst M; Schinkel AF; Michels M; van Rossum AC; Germans T; van der Velden J
    Eur J Clin Invest; 2015 Dec; 45(12):1252-9. PubMed ID: 26444145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Genetic Basis of Hypertrophic Cardiomyopathy.
    Marian AJ
    Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4D flow MRI left atrial kinetic energy in hypertrophic cardiomyopathy is associated with mitral regurgitation and left ventricular outflow tract obstruction.
    Gupta AN; Soulat G; Avery R; Allen BD; Collins JD; Choudhury L; Bonow RO; Carr J; Markl M; Elbaz MSM
    Int J Cardiovasc Imaging; 2021 Sep; 37(9):2755-2765. PubMed ID: 33523363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial Transcriptomic Analysis of Focal and Normal Areas of Myocyte Disarray in Human Hypertrophic Cardiomyopathy.
    Laird J; Perera G; Batorsky R; Wang H; Arkun K; Chin MT
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Gruner C; Chan RH; Crean A; Rakowski H; Rowin EJ; Care M; Deva D; Williams L; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Siminovitch K; Ralph-Edwards AC; Rastegar H; Maron BJ; Maron MS
    Eur Heart J; 2014 Oct; 35(39):2706-13. PubMed ID: 24810389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the extent of fibrosis in obstructive and nonobstructive hypertrophic cardiomyopathy.
    Avegliano G; Politi MT; Costabel JP; Kuschnir P; Trivi M; Ronderos R
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):389-396. PubMed ID: 30994509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the Immune Status of Hypertrophic Cardiomyopathy by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data.
    Zhao W; Wu T; Zhan J; Dong Z
    Comput Math Methods Med; 2022; 2022():7153491. PubMed ID: 36238494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.
    Sorensen LL; Liang HY; Pinheiro A; Hilser A; Dimaano V; Olsen NT; Hansen TF; Sogaard P; Nowbar A; Pisanello C; Pozios I; Phillip S; Zhou X; Abraham R; Abraham TP
    Am Heart J; 2017 Feb; 184():47-54. PubMed ID: 27892886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.